サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1453903

肺動脈弁置換の2030年までの市場予測： 弁タイプ別、施術タイプ別、用途別、エンドユーザー別、地域別の世界分析

Pulmonary Valve Replacement Market Forecasts to 2030 - Global Analysis By Valve Type, Procedure Type, Application, End User, and By Geography

出版日
ページ情報
英文 200+ Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
肺動脈弁置換の2030年までの市場予測： 弁タイプ別、施術タイプ別、用途別、エンドユーザー別、地域別の世界分析
出版日: 2024年03月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、肺動脈弁置換の世界市場は2023年に12億米ドルを占め、予測期間中にCAGR 7.1％で成長し、2030年には20億米ドルに達すると予測されています。

肺動脈弁置換（PVR）は、心臓の肺動脈弁の欠陥や損傷を置き換えることを目的とした外科手術です。肺動脈弁は、心臓の右心室から肺動脈への血流を調整し、肺での血液の酸素化を促進します。外科医は通常、機械的または生物学的人工弁を使用して、適切な心臓機能を回復させる。PVRは息切れ、胸痛、疲労などの症状を緩和し、心臓全体の健康と生活の質を向上させる。術後のケアとしては、合併症のモニタリングや心臓リハビリテーションを行い、回復と長期的な幸福をサポートします。

ヘルスケア支出の増加

新興経済諸国や先進諸国を中心にヘルスケア支出が増加するにつれて、専門的な心臓治療へのアクセスも増加しています。このようなインフラの改善により、ヘルスケアプロバイダーはより多くの患者に幅広い治療オプションを提供できるようになります。さらに、ヘルスケア支出の増加は、保険適用や償還政策の改善としばしば関連し、患者の経済的障壁を軽減します。

高コスト

手技の複雑さと侵襲性が、肺動脈弁置換の高コストの主な要因の2つです。これらの要因は、術前評価、術後ケア、経過観察などを含む手技全体のコストに寄与しています。さらに、人工弁や導管など、肺動脈弁置換に使用される材料は高価な場合があり、これがさらに手術費用を押し上げています。

技術の進歩

人工弁の設計や材料の進歩は、肺動脈弁置換の寿命、耐久性、生体適合性の向上に寄与しています。これらの技術革新は、より良い臨床転帰と弁不全率の減少をもたらし、患者満足度の向上と再手術の必要性の減少につながります。さらに、3D心エコーや心臓磁気共鳴画像法（MRI）などの画像技術の進歩が術前計画を強化し、この市場の成長を後押ししています。

認識不足

肺動脈弁疾患の症状や結果に関する認識が低いため、診断や介入が遅れ、患者の予後が悪くなる可能性があります。また、ヘルスケアプロバイダーは、技術やテクノロジーにおける最新の進歩について十分な理解がないため、患者のケアが最適化されず、適切な治療法が十分に活用されない可能性があります。さらに、患者やその家族が外科的処置について誤解や恐怖を抱いていることもあり、これがこの市場規模の妨げになることもあります。

COVID-19の影響

COVID-19の流行は肺動脈弁置換市場に大きな影響を与えました。世界中のヘルスケアシステムがパンデミックに対処するためにリソースを振り向けたため、肺動脈弁置換を含む選択的手術は遅延やキャンセルが発生しました。このため、心臓インターベンションを専門とするメーカーやヘルスケア施設では、手技件数と収益の減少につながった。さらに、患者がウイルスにさらされることを恐れて緊急性のない医療を受けたがらないことも、肺動脈弁置換の需要をさらに減退させました。

予測期間中、組織工学肺動脈弁分野が最大になる見込み

組織工学肺動脈弁セグメントは最大のシェアを占めると推定されます。これらのバルブは、生来の肺バルブの構造と機能を模倣するように設計されており、肺バルブの機能障害を持つ患者に有望なソリューションを提供します。組織工学的肺動脈弁は、通常、生分解性足場に細胞を播種することによって作製され、生体組織の成長を可能にします。さらに、組織工学によって作られた弁は、長期的な機能性と血行力学的性能の面で有望な結果を示しており、このセグメントの成長を徐々に後押ししています。

予測期間中、経カテーテル肺動脈弁置換（TPVR）分野のCAGRが最も高くなると予想される

経カテーテル肺動脈弁置換（TPVR）分野は、カテーテル治療による低侵襲な肺動脈弁置換であるため、予測期間中に最も高いCAGRが見込まれます。このアプローチは、先天性心欠損、肺動脈弁狭窄、逆流を有する患者に特に有益です。さらに、TPVR処置は、従来の外科的介入と比較して、安全性、有効性、患者の回復の面で優れた結果を示しており、これがこのセグメントの拡大を促進しています。

最大のシェアを占める地域

北米は、先天性心疾患と弁膜症の有病率の増加により、推定期間中最大の市場シェアを占めました。この地域には、メドトロニック、アボット・ラボラトリーズ、ボストン・サイエンティフィックなどの大手企業が進出しています。さらに、心血管ヘルスケアの改善や医学研究の促進を目的とした政府の取り組みも、市場の成長を促進する上で重要な役割を果たしています。

CAGRが最も高い地域：

欧州は、医療技術の著しい進歩、強固なヘルスケアシステムにより、予測期間中に最も高いCAGRを記録すると予想されます。ドイツ、フランス、英国、イタリアなどの国々が、同地域の市場成長に大きく貢献しています。さらに、欧州には医療技術革新を支える強力な規制の枠組みがあり、新しい肺動脈弁置換技術の安全性と有効性を確保し、競争を促進し、この分野の進歩を促進しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • アプリケーション分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の肺動脈弁置換市場：弁タイプ別

  • 組織工学的に作製された肺動脈弁
  • 生体人工肺弁
  • 同種移植肺弁
  • 機械式肺弁
  • その他の弁タイプ

第6章 世界の肺動脈弁置換市場：施術タイプ別

  • 経カテーテル肺動脈弁置換術（TPVR）
  • 外科的肺弁置換術（開胸手術）
  • ロボット支援による肺弁置換術
  • ロスの手順
  • 弁膜切開術
  • その他の施術タイプ

第7章 世界の肺動脈弁置換市場：用途別

  • 肺狭窄症
  • 弁機能不全
  • 先天性心臓欠陥
  • 肺逆流
  • その他の用途

第8章 世界の肺動脈弁置換市場：エンドユーザー別

  • 外来手術センター
  • 病院
  • 心臓専門クリニック
  • その他のエンドユーザー

第9章 世界の肺動脈弁置換市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第10章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第11章 企業プロファイル

  • Edwards Lifesciences
  • Medtronic
  • Terumo Corporation
  • CryoLife, Inc
  • SynCardia Systems, Inc.
  • Abbott Laboratories
  • Merit Medical Systems
  • LivaNova PLC
  • Micro Interventional Devices, Inc.
  • Boston Scientific
  • Braile Biomedica
  • JenaValve Technology, Inc.
  • B. Braun Melsungen AG
  • Medistim
  • CardioMech AS
図表

List of Tables

  • Table 1 Global Pulmonary Valve Replacement Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 3 Global Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 4 Global Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 5 Global Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 6 Global Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 7 Global Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 8 Global Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 9 Global Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 10 Global Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 11 Global Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 12 Global Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 13 Global Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 14 Global Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 15 Global Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 17 Global Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 18 Global Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 19 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 20 Global Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 Global Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 23 Global Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 Global Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 25 Global Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 26 North America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 27 North America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 28 North America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 29 North America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 30 North America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 31 North America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 32 North America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 33 North America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 34 North America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 35 North America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 36 North America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 37 North America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 38 North America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 39 North America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 40 North America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 42 North America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 43 North America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 44 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 45 North America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 North America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 North America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 48 North America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 49 North America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 50 North America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 51 Europe Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 52 Europe Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 53 Europe Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 54 Europe Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 55 Europe Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 56 Europe Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 57 Europe Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 58 Europe Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 59 Europe Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 60 Europe Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 61 Europe Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 62 Europe Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 63 Europe Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 64 Europe Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 65 Europe Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 66 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 67 Europe Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 68 Europe Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 69 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 70 Europe Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 71 Europe Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 72 Europe Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 73 Europe Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 74 Europe Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 75 Europe Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 76 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 78 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 79 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 80 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 81 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 82 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 83 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 84 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 85 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 86 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 87 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 88 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 89 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 90 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 92 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 93 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 94 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 95 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 96 Asia Pacific Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 98 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 99 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 100 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 South America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 South America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 103 South America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 104 South America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 105 South America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 106 South America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 107 South America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 108 South America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 109 South America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 110 South America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 111 South America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 112 South America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 113 South America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 114 South America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 115 South America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 116 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 117 South America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 118 South America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 119 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 120 South America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 121 South America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 122 South America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 123 South America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 124 South America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 125 South America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 126 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 127 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 128 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 129 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 130 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 131 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 132 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 133 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 134 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 135 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 136 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 137 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 138 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 139 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 141 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 142 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 143 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 144 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 145 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 146 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 147 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 148 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 149 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 150 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC25455

According to Stratistics MRC, the Global Pulmonary Valve Replacement Market is accounted for $1.2 billion in 2023 and is expected to reach $2.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Pulmonary valve replacement (PVR) is a surgical procedure aimed at replacing a defective or damaged pulmonary valve in the heart. The pulmonary valve regulates blood flow from the heart's right ventricle to the pulmonary artery, facilitating oxygenation of blood in the lungs. Surgeons typically use either mechanical or biological prosthetic valves to restore proper cardiac function. PVR can alleviate symptoms like shortness of breath, chest pain, and fatigue, improving overall heart health and quality of life. Post-operative care involves monitoring for complications and cardiac rehabilitation to support recovery and long-term well-being.

Market Dynamics:

Driver:

Increasing healthcare expenditure

As healthcare spending rises, particularly in emerging economies and developed countries, there is a corresponding increase in access to specialized cardiac care procedures. This improved infrastructure enables healthcare providers to offer a wider range of treatment options to a greater number of patients. Moreover, increased healthcare spending often correlates with improvements in insurance coverage and reimbursement policies, reducing financial barriers for patients, which drives this market growth.

Restraint:

High cost

The complexity and invasiveness of the procedure are two of the primary factors contributing to the high cost of pulmonary valve replacement. These factors contribute to the overall cost of the procedure, including pre-operative assessments, post-operative care, and follow-up visits. Additionally, the materials used in pulmonary valve replacement, such as prosthetic valves or conduits, can be expensive, further driving up the cost of the procedure.

Opportunity:

Technological advancements

Advancements in prosthetic valve design and materials contribute to improved longevity, durability, and biocompatibility of pulmonary valve replacements. These innovations result in better clinical outcomes and reduced rates of valve failure, leading to increased patient satisfaction and a decreased need for repeat interventions. Furthermore, advancements in imaging technologies, such as 3D echocardiography and cardiac magnetic resonance imaging (MRI), enhance preoperative planning, which is boosting this market growth.

Threat:

Lack of awareness

Limited awareness about the symptoms and consequences of pulmonary valve conditions may lead to delays in diagnosis and intervention, resulting in poorer patient outcomes. Healthcare providers may also lack sufficient understanding of the latest advancements in techniques and technologies, leading to suboptimal patient care and the underutilization of appropriate treatments. Furthermore, patients and their families may have misconceptions or fears about surgical procedures, which can impede this market size.

Covid-19 Impact

The COVID-19 pandemic has significantly impacted the pulmonary valve replacement market. As healthcare systems worldwide diverted resources to manage the pandemic, elective procedures, including pulmonary valve replacements, experienced delays and cancellations. This led to a reduction in procedural volumes and revenue for manufacturers and healthcare facilities specializing in cardiac interventions. Moreover, patient reluctance to seek non-urgent medical care due to fear of exposure to the virus further dampened demand for pulmonary valve replacement procedures.

The tissue engineered pulmonary valves segment is expected to be the largest during the forecast period

The tissue engineered pulmonary valves segment is estimated to hold the largest share. These valves are designed to mimic the structure and function of native pulmonary valves, offering promising solutions for patients with pulmonary valve dysfunction. Tissue-engineered pulmonary valves are typically created by seeding cells onto a biodegradable scaffold, allowing for the growth of living tissue. Additionally, tissue-engineered valves have shown promising outcomes in terms of long-term functionality and hemodynamic performance, which gradually boosts this segment's growth.

The transcatheter pulmonary valve replacement (TPVR) segment is expected to have the highest CAGR during the forecast period

The transcatheter pulmonary valve replacement (TPVR) segment is anticipated to have highest CAGR during the forecast period due to its minimally invasive procedure for replacing pulmonary valves via catheterization. This approach is particularly beneficial for patients with congenital heart defects, pulmonary valve stenosis, or regurgitation. Furthermore, TPVR procedures have demonstrated excellent outcomes in terms of safety, efficacy, and patient recovery, compared to traditional surgical interventions, which are driving this segment's expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to a growing prevalence of congenital heart diseases and valve disorders. This region is home to some of the major players, such as Medtronic, Abbott Laboratories, and Boston Scientific. Moreover, government initiatives aimed at improving cardiovascular healthcare and advancing medical research also play a vital role in fueling market growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to significant advancements in medical technology, robust healthcare systems. Countries like Germany, France, the United Kingdom, and Italy are key contributors to the market's growth in the region. Additionally, Europe has a strong regulatory framework supporting medical innovation, ensuring the safety and efficacy of new pulmonary valve replacement technologies, fostering competition, and driving advancements in the field.

Key players in the market

Some of the key players in the Pulmonary Valve Replacement Market include Edwards Lifesciences, Medtronic, Terumo Corporation, CryoLife, Inc, SynCardia Systems, Inc., Abbott Laboratories, Merit Medical Systems, LivaNova PLC, Micro Interventional Devices, Inc., Boston Scientific, Braile Biomedica, JenaValve Technology, Inc., B. Braun Melsungen AG, Medistim and CardioMech AS.

Key Developments:

In January 2024, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.

In December 2023, Medtronic plc announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral(TM) renal denervation (RDN) system, also known as the Symplicity(TM) blood pressure procedure, for the treatment of hypertension.

In September 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX(TM) Pro Left Atrial Appendage Closure (LAAC) Device.

Valve Types Covered:

  • Tissue Engineered Pulmonary Valves
  • Bioprosthetic Pulmonary Valves
  • Homograft Pulmonary Valves
  • Mechanical Pulmonary Valves
  • Other Valve Types

Procedure Types Covered:

  • Transcatheter Pulmonary Valve Replacement (TPVR)
  • Surgical Pulmonary Valve Replacement (Open-heart surgery)
  • Robotic-Assisted Pulmonary Valve Replacement
  • Ross Procedure
  • Valvulotomy
  • Other Procedure Types

Applications Covered:

  • Pulmonary Stenosis
  • Valve Dysfunction
  • Congenital Heart Defects
  • Pulmonary Regurgitation
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Cardiac Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pulmonary Valve Replacement Market, By Valve Type

  • 5.1 Introduction
  • 5.2 Tissue Engineered Pulmonary Valves
  • 5.3 Bioprosthetic Pulmonary Valves
  • 5.4 Homograft Pulmonary Valves
  • 5.5 Mechanical Pulmonary Valves
  • 5.6 Other Valve Types

6 Global Pulmonary Valve Replacement Market, By Procedure Type

  • 6.1 Introduction
  • 6.2 Transcatheter Pulmonary Valve Replacement (TPVR)
  • 6.3 Surgical Pulmonary Valve Replacement (Open-heart surgery)
  • 6.4 Robotic-Assisted Pulmonary Valve Replacement
  • 6.5 Ross Procedure
  • 6.6 Valvulotomy
  • 6.7 Other Procedure Types

7 Global Pulmonary Valve Replacement Market, By Application

  • 7.1 Introduction
  • 7.2 Pulmonary Stenosis
  • 7.3 Valve Dysfunction
  • 7.4 Congenital Heart Defects
  • 7.5 Pulmonary Regurgitation
  • 7.6 Other Applications

8 Global Pulmonary Valve Replacement Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Cardiac Specialty Clinics
  • 8.5 Other End Users

9 Global Pulmonary Valve Replacement Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Edwards Lifesciences
  • 11.2 Medtronic
  • 11.3 Terumo Corporation
  • 11.4 CryoLife, Inc
  • 11.5 SynCardia Systems, Inc.
  • 11.6 Abbott Laboratories
  • 11.7 Merit Medical Systems
  • 11.8 LivaNova PLC
  • 11.9 Micro Interventional Devices, Inc.
  • 11.10 Boston Scientific
  • 11.11 Braile Biomedica
  • 11.12 JenaValve Technology, Inc.
  • 11.13 B. Braun Melsungen AG
  • 11.14 Medistim
  • 11.15 CardioMech AS